Biotech’s road to recovery with 46% increase in Q1 venture funding
Investor optimism in biotech has increased due to the expected lowering of interest rates as inflation slows.
Investor optimism in biotech has increased due to the expected lowering of interest rates as inflation slows.
What's Your Reaction?
